{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:44:08Z","timestamp":1790214248092,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,24]],"date-time":"2018-01-24T00:00:00Z","timestamp":1516752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,24]],"date-time":"2018-01-24T00:00:00Z","timestamp":1516752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We investigated whether pre-treatment with statins is associated with surrogate markers of amyloid and hypertensive angiopathies in patients who need to start long-term oral anticoagulation therapy. A prospective multicenter study of patients naive for oral anticoagulants, who had an acute cardioembolic stroke. MRI was performed at admission to evaluate microbleeds, leukoaraiosis and superficial siderosis. We collected data on the specific statin compound, the dose and the statin intensity. We performed bivariate analyses and a logistic regression to investigate variables associated with microbleeds. We studied 470 patients (age 77.5\u2009\u00b1\u20096.4 years, 43.7% were men), and 193 (41.1%) of them received prior treatment with a statin. Microbleeds were detected in 140 (29.8%), leukoaraiosis in 388 (82.5%) and superficial siderosis in 20 (4.3%) patients. The presence of microbleeds, leukoaraiosis or superficial siderosis was not related to pre-treatment with statins. Microbleeds were more frequent in patients with prior intracerebral hemorrhage (OR 9.7, 95% CI 1.06\u201390.9) and in those pre-treated antiplatelets (OR 1.66, 95% CI 1.09\u20132.53). Prior treatment with statins was not associated with markers of bleeding-prone cerebral angiopathies in patients with cardioembolic stroke. Therefore, previous statin treatment should not influence the decision to initiate or withhold oral anticoagulation if these neuroimaging markers are detected.<\/jats:p>","DOI":"10.1038\/s41598-018-20055-3","type":"journal-article","created":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T11:04:34Z","timestamp":1516273474000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Statins do not increase Markers of Cerebral Angiopathies in patients with Cardioembolic Stroke"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9229-8649","authenticated-orcid":false,"given":"Joan","family":"Mart\u00ed-F\u00e0bregas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Medrano-Martorell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Merino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Prats-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Delgado-Mederos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pol","family":"Camps-Renom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Mart\u00ednez-Dome\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"G\u00f3mez-Choco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Lara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Casado-Naranjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"C\u00e1novas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jos\u00e9","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marimar","family":"Freijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Calleja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Cocho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Rodr\u00edguez-Campello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Zandio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"de Felipe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Llull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Maestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mois\u00e8s","family":"Garc\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria","family":"De Arce-Borda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Palomeras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Rodr\u00edguez-Y\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inma","family":"D\u00edaz-Maroto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9ssica","family":"Fern\u00e1ndez-Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Sanahuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Purroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marialuisa","family":"Zedde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Delgado-Mengual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignasi","family":"Gich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,24]]},"reference":[{"key":"20055_CR1","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/STROKEAHA.112.668277","volume":"44","author":"D N\u00ed Chr\u00f3in\u00edn","year":"2013","unstructured":"N\u00ed Chr\u00f3in\u00edn, D. et al. Statin therapy and outcome after ischemic stroke: systematic review and meta-analysis of observational studies and randomized trials. Stroke. 44, 448\u2013456 (2013).","journal-title":"Stroke."},{"key":"20055_CR2","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1056\/NEJMoa061894","volume":"355","author":"P Amarenco","year":"2006","unstructured":"Amarenco, P. et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 355, 549\u2013559 (2006).","journal-title":"N Engl J Med."},{"key":"20055_CR3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1161\/CIRCULATIONAHA.112.145334","volume":"127","author":"F Violi","year":"2013","unstructured":"Violi, F., Calvieri, C., Ferro, D. & Pignatelli, P. Statins as antithrombotic drugs. Circulation. 127, 251\u2013257 (2013).","journal-title":"Circulation."},{"key":"20055_CR4","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1161\/STROKEAHA.114.004130","volume":"45","author":"JR Romero","year":"2014","unstructured":"Romero, J. R. et al. Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study. Stroke. 45, 1492\u20131494 (2014).","journal-title":"Stroke."},{"key":"20055_CR5","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1161\/STROKEAHA.112.657486","volume":"43","author":"DC Haussen","year":"2012","unstructured":"Haussen, D. C., Henninger, N., Kumar, S. & Selim, M. Statin use and microbleeds in patients with spontaneous intracerebral hemorrhage. Stroke. 43, 2677\u20132681 (2012).","journal-title":"Stroke."},{"key":"20055_CR6","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1161\/STROKEAHA.110.594101","volume":"42","author":"JS Day","year":"2011","unstructured":"Day, J. S. et al. Previous statin use is not associated with an increased prevalence or degree of gradient-echo lesions in patients with acute ischemic stroke or transient ischemic attack. Stroke. 42, 354\u2013358 (2011).","journal-title":"Stroke."},{"key":"20055_CR7","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1007\/s13311-014-0270-5","volume":"11","author":"Y Xiong","year":"2014","unstructured":"Xiong, Y. et al. Prestroke statins, progression of white matter hyperintensities, and cognitive decline in stroke patients with confluent white matter hyperintensities. Neurotherapeutics. 11, 606\u2013611 (2014).","journal-title":"Neurotherapeutics."},{"key":"20055_CR8","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/jnnp-2015-312736","volume":"87","author":"A Pezzini","year":"2016","unstructured":"Pezzini, A. et al. Serum cholesterol levels, HMG-CoA reductase inhibitors and the risk of intracerebral haemorrhage. The Multicenter Study on Cerebral Haemorrhage in Italy (MUCH-Italy). J Neurol Neurosurg Psychiatry. 87, 924\u2013929 (2016).","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"20055_CR9","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1161\/01.STR.0000036092.23649.2E","volume":"33","author":"SH Lee","year":"2002","unstructured":"Lee, S. H. et al. Low concentration of serum total cholesterol is associated with multifocal signal loss lesions on gradient-echo magnetic resonance imaging: analysis of risk factors for multifocal signal loss lesions. Stroke 33, 2845\u20132849 (2002).","journal-title":"Stroke"},{"key":"20055_CR10","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1161\/STROKEAHA.113.001304","volume":"44","author":"D Woo","year":"2013","unstructured":"Woo, D. et al. Apolipoprotein E, statins, and risk of intracerebral hemorrhage. Stroke. 44, 3013\u20133017 (2013).","journal-title":"Stroke."},{"key":"20055_CR11","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1136\/jnnp.2009.198994","volume":"81","author":"SM Gregoire","year":"2010","unstructured":"Gregoire, S. M. et al. Brain microbleeds as a potential risk factor for antiplatelet-related intracerebral haemorrhage: hospital-based, case-control study. J Neurol Neurosurg Psychiatry. 81, 679\u2013684 (2010).","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"20055_CR12","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1161\/STROKEAHA.114.005151","volume":"45","author":"ES van Etten","year":"2014","unstructured":"van Etten, E. S. et al. Incidence of symptomatic hemorrhage in patients with lobar microbleeds. Stroke. 45, 2280\u20132285 (2014).","journal-title":"Stroke."},{"key":"20055_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1212\/01.wnl.0000339060.11702.dd","volume":"72","author":"SH Lee","year":"2009","unstructured":"Lee, S. H., Ryu, W. S. & Roh, J. K. Cerebral microbleeds are a risk factor for warfarin-related intracerebral hemorrhage. Neurology. 72, 171\u2013176 (2009).","journal-title":"Neurology."},{"issue":"25 Pt B","key":"20055_CR14","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","volume":"63","author":"NJ Stone","year":"2014","unstructured":"Stone, N. J. et al. ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63(25 Pt B), 2889\u20132934 (2014).","journal-title":"J Am Coll Cardiol"},{"key":"20055_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2214\/ajr.149.2.351","volume":"149","author":"F Fazekas","year":"1987","unstructured":"Fazekas, F., Chawluk, J. B., Alavi, A., Hurtig, H. I. & Zimmerman, R. A. MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging. AJR Am J Roentgenol. 149, 351\u2013356 (1987).","journal-title":"AJR Am J Roentgenol."},{"key":"20055_CR16","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1093\/brain\/awv162","volume":"138","author":"A Charidimou","year":"2015","unstructured":"Charidimou, A. et al. Cortical superficial siderosis: detection and clinical significance in cerebral amyloid angiopathy and related conditions. Brain. 138, 2126\u20132139 (2015).","journal-title":"Brain."},{"key":"20055_CR17","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1161\/STROKEAHA.107.488791","volume":"39","author":"MD Vergouwen","year":"2008","unstructured":"Vergouwen, M. D., de Haan, R. J., Vermeulen, M. & Roos, Y. B. Statin treatment and the occurrence of hemorrhagic stroke in patients with a history of cerebrovascular disease. Stroke. 39, 497\u2013502 (2008).","journal-title":"Stroke."},{"key":"20055_CR18","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1161\/STROKEAHA.113.002751","volume":"45","author":"JF Scheitz","year":"2014","unstructured":"Scheitz, J. F. et al. Dose-related effects of statins on symptomatic intracerebral hemorrhage and outcome after thrombolysis for ischemic stroke. Stroke. 45, 509\u2013514 (2014).","journal-title":"Stroke."},{"key":"20055_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00415-011-6137-3","volume":"259","author":"S Martinez-Ramirez","year":"2012","unstructured":"Martinez-Ramirez, S. et al. Statin pretreatment may increase the risk of symptomatic intracranial haemorrhage in thrombolysis for ischemic stroke: results from a case-control study and a meta-analysis. J Neurol. 259, 111\u2013118 (2012).","journal-title":"J Neurol."},{"key":"20055_CR20","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1212\/01.wnl.0000252799.64165.d5","volume":"68","author":"OY Bang","year":"2007","unstructured":"Bang, O. Y. et al. Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis. Neurology. 68, 737\u2013742 (2007).","journal-title":"Neurology."},{"key":"20055_CR21","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1161\/STROKEAHA.108.532473","volume":"40","author":"N Meier","year":"2009","unstructured":"Meier, N. et al. Prior statin use, intracranial hemorrhage, and outcome after intra-arterial thrombolysis for acute ischemic stroke. Stroke. 40, 1729\u20131737 (2009).","journal-title":"Stroke."},{"key":"20055_CR22","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0140-6736(04)15690-0","volume":"363","author":"R Collins","year":"2004","unstructured":"Collins, R., Armitage, J., Parish, S., Sleight, P. & Peto, R. Heart Protection Study Collaborative G. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet. 363, 757\u2013767 (2004).","journal-title":"Lancet."},{"key":"20055_CR23","doi-asserted-by":"crossref","unstructured":"Cholesterol Treatment Trialists\u2019 (CTT) Collaboration. et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials. Lancet, 376:1670\u20131681 (2010).","DOI":"10.1016\/S0140-6736(10)61350-5"},{"key":"20055_CR24","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1161\/CIRCULATIONAHA.111.055269","volume":"124","author":"DG Hackam","year":"2011","unstructured":"Hackam, D. G. et al. Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis. Circulation. 124, 2233\u20132242 (2011).","journal-title":"Circulation."},{"key":"20055_CR25","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1161\/STROKEAHA.112.655894","volume":"43","author":"JS McKinney","year":"2012","unstructured":"McKinney, J. S. & Kostis, W. J. Statin therapy and the risk of intracerebral hemorrhage: a meta-analysis of 31 randomized controlled trials. Stroke. 43, 2149\u20132156 (2012).","journal-title":"Stroke."},{"key":"20055_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11883-015-0526-5","volume":"17","author":"A Lauer","year":"2015","unstructured":"Lauer, A., Greenberg, S. M. & Gurol, M. E. Statins in Intracerebral Hemorrhage. Curr Atheroscler Rep. 17, 46 (2015).","journal-title":"Curr Atheroscler Rep."},{"key":"20055_CR27","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1161\/STROKEAHA.113.001326","volume":"44","author":"X Wang","year":"2013","unstructured":"Wang, X., Dong, Y., Qi, X., Huang, C. & Hou, L. Cholesterol levels and risk of hemorrhagic stroke: a systematic review and meta-analysis. Stroke. 44, 1833\u20131839 (2013).","journal-title":"Stroke."},{"key":"20055_CR28","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1161\/01.STR.0000127786.16612.A4","volume":"35","author":"D Woo","year":"2004","unstructured":"Woo, D. et al. Hypercholesterolemia, HMG-CoA reductase inhibitors, and risk of intracerebral hemorrhage: a case-control study. Stroke. 35, 1360\u20131364 (2004).","journal-title":"Stroke."},{"key":"20055_CR29","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1002\/phar.1674","volume":"35","author":"A Sikora Newsome","year":"2015","unstructured":"Sikora Newsome, A. et al. The Role of Statin Therapy in Hemorrhagic Stroke. Pharmacotherapy. 35, 1152\u20131163 (2015).","journal-title":"Pharmacotherapy."},{"key":"20055_CR30","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1212\/01.wnl.0000296277.63350.77","volume":"70","author":"LB Goldstein","year":"2008","unstructured":"Goldstein, L. B. et al. Hemorrhagic stroke in the stroke prevention by aggressive reduction in cholesterol levels study. Neurology. 70, 2364\u20132370 (2008).","journal-title":"Neurology."},{"key":"20055_CR31","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1056\/NEJMoa1501031","volume":"372","author":"JG Robinson","year":"2015","unstructured":"Robinson, J. G. et al. Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. N Engl J Med. 372, 1489\u20131499 (2015).","journal-title":"N Engl J Med."},{"key":"20055_CR32","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1056\/NEJMoa1500858","volume":"372","author":"MS Sabatine","year":"2015","unstructured":"Sabatine, M. S. et al. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. N Engl J Med. 372, 1500\u20131509 (2015).","journal-title":"N Engl J Med."},{"key":"20055_CR33","first-page":"637","volume":"20","author":"F Fazekas","year":"1999","unstructured":"Fazekas, F. et al. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol. 20, 637\u2013642 (1999).","journal-title":"AJNR Am J Neuroradiol."},{"key":"20055_CR34","doi-asserted-by":"publisher","first-page":"e0156992","DOI":"10.1371\/journal.pone.0156992","volume":"11","author":"J Mart\u00ed-F\u00e0bregas","year":"2016","unstructured":"Mart\u00ed-F\u00e0bregas, J. et al. The H-ATOMIC Criteria for the Etiologic Classification of Patients with Intracerebral Hemorrhage. PLoS One. 11, e0156992 (2016).","journal-title":"PLoS One."},{"key":"20055_CR35","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1001\/archneurol.2010.356","volume":"68","author":"MB Westover","year":"2011","unstructured":"Westover, M. B., Bianchi, M. T., Eckman, M. H. & Greenberg, S. M. Statin use following intracerebral hemorrhage: a decision analysis. Arch Neurol. 68, 573\u2013579 (2011).","journal-title":"Arch Neurol."},{"key":"20055_CR36","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1093\/brain\/awl387","volume":"130","author":"C Cordonnier","year":"2007","unstructured":"Cordonnier, C., Al-Shahi Salman, R. & Wardlaw, J. Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain. 130, 1988\u20132003 (2007).","journal-title":"Brain."},{"key":"20055_CR37","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1161\/STROKEAHA.109.572594","volume":"41","author":"CE Lovelock","year":"2010","unstructured":"Lovelock, C. E., Cordonnier, C., Naka, H., Al-Shahi Salman, R. & Sudlow, C. L. Edinburgh Stroke Study Group, et al. Antithrombotic drug use, cerebral microbleeds, and intracerebral hemorrhage: a systematic review of published and unpublished studies. Stroke. 41, 1222\u20131228 (2010).","journal-title":"Stroke."},{"key":"20055_CR38","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1161\/01.ATV.0000038754.39483.CD","volume":"22","author":"W Palinski","year":"2002","unstructured":"Palinski, W. & Napoli, C. Unraveling pleiotropic effects of statins on plaque rupture. Arterioscler Thromb Vasc Biol 22, 1745\u20131750 (2002).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"20055_CR39","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.pharmthera.2016.11.001","volume":"170","author":"M Banach","year":"2017","unstructured":"Banach, M. et al. Intensive LDL-cholesterol lowering therapy and neurocognitive function. Pharmacol Ther. 170, 181\u2013191 (2017).","journal-title":"Pharmacol Ther."},{"key":"20055_CR40","doi-asserted-by":"publisher","first-page":"585","DOI":"10.2165\/10558450-000000000-00000","volume":"26","author":"M Enajat","year":"2009","unstructured":"Enajat, M. et al. Safety of the combination of intensive cholesterol-lowering therapy with oral anticoagulation medication in elderly patients with atrial fibrillation: a randomized, double-blind, placebo-controlled study. Drugs Aging. 26, 585\u2013593 (2009).","journal-title":"Drugs Aging."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20055-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20055-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20055-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T01:31:08Z","timestamp":1671586268000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20055-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,24]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["20055"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-20055-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,24]]},"assertion":[{"value":"2 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1492"}}